Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study

OBJECTIVES: Compared with controls, multiple sclerosis (MS) patients die, on average, 7–14 years prematurely. Previously, we reported that, 21 years after their participation in the pivotal randomised, controlled trial (RCT) of interferon β-1b, mortality was reduced by 46–47% in the two groups who r...

Full description

Saved in:
Bibliographic Details
Main Authors: Goodin, Douglas S, Ebers, George C, Cutter, Gary, Cook, Stuart D, O'Donnell, Timothy, Reder, Anthony T, Kremenchutzky, Marcelo, Oger, Joel, Rametta, Mark, Beckmann, Karola, Knappertz, Volker
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2012
Subjects:
Neurology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533062/
https://ncbi.nlm.nih.gov/pubmed/23204140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-001972
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items